| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |